Literature DB >> 2190358

Mutagenicity, metabolism, and DNA interactions of urethane.

R E Sotomayor1, T F Collins.   

Abstract

Urethane, a known animal carcinogen, has been the subject of intensive research efforts spanning 40 years. Recent concerns have focused on the presence of urethane in a variety of fermented foods and alcoholic beverages, although no epidemiological studies or human case reports have been published. Much information is available about the mutagenesis, metabolism, and DNA interactions of urethane in experimental systems. Urethane is generally not mutagenic in bacteria although in some instances it acts as a weak mutagen. Urethane is not mutagenic in Nuerospora but is weakly mutagenic in Saccharomyces. Drosophila appear to be the only organisms that consistently give positive mutagenic results with urethane, but its mutagenicity is weak and in many cases shows no clear dose dependence. Urethane is a good clastogen in mammalian somatic cells in vivo, but it shows variable results with cells in vitro. It efficiently induces sister chromatid exchanges in a variety of cells. Mammalian spermatogenic cells are insensitive to the induction of specific locus and dominant lethal mutations by urethane. Mutational synergism has been reported to occur between ethyl methanesulfonate and urethane when administered two generations apart, and some investigators have suggested possible synergism for cancer-causing mutations in mice exposed to X-rays and urethane one generation apart. These studies are controversial and have not been confirmed. Studies on the induction of cancer-causing dominant mutations by urethane are at variance with results from extensive studies with the specific locus test in mice. Urethane studies with the unscheduled DNA synthesis assay in mouse spermatogenic cells and with the sperm abnormality test have given negative results. Urethane is rapidly and evenly distributed in the body. The rate of elimination of urethane from plasma is a saturable process and varies according to the strain and age of the animal. Recent studies have concentrations similar to those in wine, ethanol inhibits the tissue distribution of urethane in mice. These results are important because they suggest a lower carcinogenic/mutagenic risk than expected from exposure to urethane in alcoholic beverages. Although research on the metabolic activation of urethane has been extensive, no conclusive results have been obtained about its active metabolite, at one time thought to be N-hydroxyurethane. More recently, it has been postulated that urethane is activated to vinyl carbamate and that this metabolite is capable of reacting with DNA.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190358     DOI: 10.1177/074823379000600106

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  4 in total

Review 1.  Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test.

Authors:  D J Tweats; D Blakey; R H Heflich; A Jacobs; S D Jacobsen; T Morita; T Nohmi; M R O'Donovan; Y F Sasaki; T Sofuni; R Tice
Journal:  Mutat Res       Date:  2006-11-20       Impact factor: 2.433

2.  Integration of Pig-a, micronucleus, chromosome aberration and comet assay endpoints in a 28-day rodent toxicity study with urethane.

Authors:  Leon F Stankowski; Marilyn J Aardema; Timothy E Lawlor; Kamala Pant; Shambhu Roy; Yong Xu; Reem Elbekai
Journal:  Mutagenesis       Date:  2015-05-01       Impact factor: 3.000

3.  A Comparison of Brain-State Dynamics across Common Anesthetic Agents in Male Sprague-Dawley Rats.

Authors:  Rachel Ward-Flanagan; Alto S Lo; Elizabeth A Clement; Clayton T Dickson
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

4.  Cyclic and sleep-like spontaneous alternations of brain state under urethane anaesthesia.

Authors:  Elizabeth A Clement; Alby Richard; Megan Thwaites; Jonathan Ailon; Steven Peters; Clayton T Dickson
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.